These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3277491

  • 1. Calcium antagonists as a new treatment modality in hypertension.
    Laragh JH.
    Angiology; 1988 Jan; 39(1 Pt 2):100-5. PubMed ID: 3277491
    [Abstract] [Full Text] [Related]

  • 2. Clinical parameters of concern in the pathology and treatment of hypertension.
    Laragh JH.
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):1S-11S. PubMed ID: 2947978
    [Abstract] [Full Text] [Related]

  • 3. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH, Resnick LM.
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [Abstract] [Full Text] [Related]

  • 4. The significance of calcium and calcium channel blockade in essential hypertension.
    Resnick LM, Laragh JH.
    J Hypertens Suppl; 1985 Dec; 3(3):S541-4. PubMed ID: 2856782
    [Abstract] [Full Text] [Related]

  • 5. [The specificity of the hypotensive effect of calcium antagonists in hypertension].
    Ivleva AIa, Kobalava ZhD, Antiia ID, Krasnobaeva GM, Iartsev VE, Lepakhin VK, Moiseev VS.
    Ter Arkh; 1991 Dec; 63(9):97-100. PubMed ID: 1759235
    [Abstract] [Full Text] [Related]

  • 6. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J, Jakubíková K, Hrnciarová M, Kreze A, Chamulová M.
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [Abstract] [Full Text] [Related]

  • 7. Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.
    Sowers JR, Mohanty PK.
    Circulation; 1987 Jun; 75(6 Pt 2):V170-3. PubMed ID: 3552313
    [Abstract] [Full Text] [Related]

  • 8. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y, Jacob RF, Mason RP.
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [Abstract] [Full Text] [Related]

  • 9. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR.
    Z Kardiol; 1984 Oct; 73 Suppl 2():95-9. PubMed ID: 6152093
    [Abstract] [Full Text] [Related]

  • 10. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR.
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [Abstract] [Full Text] [Related]

  • 11. Calcium metabolism in essential hypertension: relationship to altered renin system activity.
    Resnick LM, Nicholson JP, Laragh JH.
    Fed Proc; 1986 Nov; 45(12):2739-45. PubMed ID: 3533639
    [Abstract] [Full Text] [Related]

  • 12. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
    Elliott HL.
    J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
    [Abstract] [Full Text] [Related]

  • 13. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Dec; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of action and clinical use of calcium antagonists in hypertension.
    Kiowski W, Bolli P, Erne P, Müller FB, Hulthén UL, Bühler FR.
    Circulation; 1989 Dec; 80(6 Suppl):IV136-44. PubMed ID: 2557176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations].
    Andréjak M, Slama M, Hary L.
    Therapie; 1998 Dec; 53(3):291-300. PubMed ID: 9773129
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL.
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [Abstract] [Full Text] [Related]

  • 19. Effects of antihypertensive therapy with angiotensin converting enzyme inhibitors or calcium antagonists on spontaneous cyclic vasomotor activity in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Salvetti M, Cinelli A, Agabiti-Rosei E.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1827-32. PubMed ID: 8903661
    [Abstract] [Full Text] [Related]

  • 20. Calcium antagonists in hypertension.
    Bühler FR, Kiowski W.
    J Hypertens Suppl; 1987 Aug; 5(3):S3-10. PubMed ID: 3312526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.